39
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Deciphering the Role of Lipid Droplets in Cardiovascular Disease: A Report from the 2017 National Heart, Lung, and Blood Institute Workshop

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Lipid droplets (LDs) are distinct and dynamic organelles that affect the health of cells and organs. Much progress has been made in understanding how these structures are formed, how they interact with other cellular organelles, how they are used for storage of triacylglycerol (TAG) in adipose tissue, and how they regulate lipolysis. Our understanding of the biology of LDs in the heart and vascular tissue is relatively primitive compared to LDs in adipose tissue and liver. The National Heart, Lung, and Blood Institute (NHLBI) convened a working group to discuss how LDs affect cardiovascular diseases (CVD). The goal of the working group was to examine the current state of knowledge on the cell biology of LDs, including current methods to study them in cells and organs and reflect on how LDs influence the development and progression of CVDs. This review summarizes the working group discussion and recommendations on research areas ripe for future investigation that will likely improve our understanding of atherosclerosis and heart function.

          Related collections

          Most cited references68

          • Record: found
          • Abstract: found
          • Article: not found

          FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and Signaling

          Lipolysis is defined as the catabolism of triacylglycerols stored in cellular lipid droplets. Recent discoveries of essential lipolytic enzymes and characterization of numerous regulatory proteins and mechanisms have fundamentally changed our perception of lipolysis and its impact on cellular metabolism. New findings that lipolytic products and intermediates participate in cellular signaling processes and that “lipolytic signaling” is particularly important in many nonadipose tissues unveil a previously underappreciated aspect of lipolysis, which may be relevant for human disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1.

            Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that regulate genes involved in energy metabolism and inflammation. For biological activity, PPARs require cognate lipid ligands, heterodimerization with retinoic X receptors, and coactivation by PPAR-γ coactivator-1α or PPAR-γ coactivator-1β (PGC-1α or PGC-1β, encoded by Ppargc1a and Ppargc1b, respectively). Here we show that lipolysis of cellular triglycerides by adipose triglyceride lipase (patatin-like phospholipase domain containing protein 2, encoded by Pnpla2; hereafter referred to as Atgl) generates essential mediator(s) involved in the generation of lipid ligands for PPAR activation. Atgl deficiency in mice decreases mRNA levels of PPAR-α and PPAR-δ target genes. In the heart, this leads to decreased PGC-1α and PGC-1β expression and severely disrupted mitochondrial substrate oxidation and respiration; this is followed by excessive lipid accumulation, cardiac insufficiency and lethal cardiomyopathy. Reconstituting normal PPAR target gene expression by pharmacological treatment of Atgl-deficient mice with PPAR-α agonists completely reverses the mitochondrial defects, restores normal heart function and prevents premature death. These findings reveal a potential treatment for the excessive cardiac lipid accumulation and often-lethal cardiomyopathy in people with neutral lipid storage disease, a disease marked by reduced or absent ATGL activity.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The perilipin family of lipid droplet proteins: Gatekeepers of intracellular lipolysis.

              Lipid droplets in chordates are decorated by two or more members of the perilipin family of lipid droplet surface proteins. The perilipins sequester lipids by protecting lipid droplets from lipase action. Their relative expression and protective nature is adapted to the balance of lipid storage and utilization in specific cells. Most cells of the body have tiny lipid droplets with perilipins 2 and 3 at the surfaces, whereas specialized fat-storing cells with larger lipid droplets also express perilipins 1, 4, and/or 5. Perilipins 1, 2, and 5 modulate lipolysis by controlling the access of lipases and co-factors of lipases to substrate lipids stored within lipid droplets. Although perilipin 2 is relatively permissive to lipolysis, perilipins 1 and 5 have distinct control mechanisms that are altered by phosphorylation. Here we evaluate recent progress toward understanding functions of the perilipins with a focus on their role in regulating lipolysis and autophagy. This article is part of a Special Issue entitled: Recent Advances in Lipid Droplet Biology edited by Rosalind Coleman and Matthijs Hesselink.
                Bookmark

                Author and article information

                Journal
                0147763
                2979
                Circulation
                Circulation
                Circulation
                0009-7322
                1524-4539
                6 June 2018
                17 July 2018
                17 July 2019
                : 138
                : 3
                : 305-315
                Affiliations
                [1 ]New York University, New York City, NY
                [2 ]University of California, Los Angeles, Los Angeles, CA
                [3 ]Washington University in St. Louis, St. Louis, MO
                [4 ]University of Texas Southwestern Medical Center, Dallas, TX
                [5 ]University of North Carolina at Chapel Hill, Chapel Hill, NC
                [6 ]National Institutes of Health/National, Heart, Lung, and Blood Institute, Bethesda, MD
                [7 ]Wayne State University, Detroit, MI
                [8 ]The Ohio State University Wexner Medical Center, Columbus, OH
                [9 ]University of Colorado Denver, Denver, CO
                [10 ]Yale University, Howard Hughes Medical Institute, New Haven, CT
                [11 ]Harvard University, Howard Hughes Medical Institute, Boston, MA
                Author notes
                Correspondence to: Jue Chen, PhD, Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Rm 8160, 6701 Rockledge Drive, Bethesda, MD 20892, Email: jue.chen@ 123456nih.gov , Phone: 301-435-0550
                Article
                PMC6056021 PMC6056021 6056021 nihpa970644
                10.1161/CIRCULATIONAHA.118.033704
                6056021
                30012703
                5797979b-51ee-497e-8384-8b68b2d7b5c4
                History
                Categories
                Article

                obesity,heart failure,metabolic syndrome,atherosclerosis,triglyceride

                Comments

                Comment on this article